Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy After Surgical Orbital Decompression

医学 视神经病变 外科减压 外科 减压 眼科 视神经
作者
Nicola Currò,Claudio Guastella,Giacinta Pirola,Barbara Calonghi,Alessandra Bottari de Castello,Maria Chiara Fazio,Sabina di Benedetto,Valeria Minorini,Marco Daga,Andrea Contarino,Ilaria Muller,Maura Arosio,Francesco Viola,Lorenzo Pignataro,Mario Salvi
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:33 (6): 743-751 被引量:3
标识
DOI:10.1089/thy.2022.0564
摘要

Background: Current guidelines suggest high-dose steroids as first-line treatment for dysthyroid optic neuropathy (DON). When steroids fail, decompressive surgery is mandatory. Methods: We conducted a single-center, retrospective cohort study in a tertiary care combined Thyroid-Eye clinic in Milan, Italy. We studied 88 orbits of 56 patients that were submitted to surgical orbital decompression to treat DON from 2005 to 2020. Of these, 33 orbits (37.5%) underwent surgery as first-line treatment for DON whereas the other 55 (62.5%) were decompressed after being unresponsive to very high-dose steroids. Previous orbital surgery, concurrent neurological or ophthalmologic diseases, or incomplete follow-up were considered as exclusion criteria from this study. Surgery was considered successful if no further decompression was needed to preserve vision. Pinhole best corrected visual acuity (p-BCVA), color sensitivity, automated visual field, pupil reflexes, optic disk and fundus appearance, exophtalmometry, and ocular motility were studied before and after surgery (1 week, 1, 3, 6, and 12 months). Activity of Graves' Orbitopathy (GO) was graded using a clinical activity score (CAS). Results: Surgery was successful in 77 orbits (87.5%). The remaining 11 orbits (12.5%) needed further surgery to treat DON definitively. All parameters of visual function improved significantly at follow-up and GO inactivated (CAS <3) within 1 month. At 3 months, all 77 responding orbits had p-BCVA >0.63 whereas all of the 11 non-responding orbits had p-BCVA ≤0.63. Visual field parameters and color sensitivity were not associated with response to surgery. High-dose steroid treatment before surgery was associated with a better response rate (96% vs. 73%; p = 0.004). Balanced decompression was associated with a higher response rate compared with medial wall decompression (96% vs. 80%; p = 0.04). A significant inverse correlation was observed between final p-BCVA and the patient's age (r = -0.42; p = 0.0003). Conclusions: Surgical decompression was found to be a very effective treatment for DON. In this study, all clinical parameters improved after surgery and further intervention was rarely needed.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
归尘发布了新的文献求助10
刚刚
hkh发布了新的文献求助10
1秒前
牛奶开水完成签到 ,获得积分10
2秒前
充电宝应助Os采纳,获得10
2秒前
钱来完成签到,获得积分10
2秒前
3秒前
leon881212发布了新的文献求助10
3秒前
cosy发布了新的文献求助10
3秒前
One应助xu采纳,获得20
3秒前
4秒前
Aba完成签到,获得积分10
4秒前
伊祁夜明完成签到,获得积分10
4秒前
5秒前
Jeff发布了新的文献求助10
5秒前
5秒前
5秒前
5秒前
依依发布了新的文献求助10
5秒前
5秒前
Albert_Z完成签到,获得积分10
6秒前
7秒前
顾矜应助123采纳,获得10
8秒前
牛马完成签到,获得积分10
9秒前
9秒前
呜呜发布了新的文献求助30
9秒前
9秒前
不喜发布了新的文献求助10
9秒前
归尘发布了新的文献求助10
10秒前
wadiu完成签到,获得积分20
10秒前
Ling发布了新的文献求助10
10秒前
Ava应助Tail采纳,获得10
11秒前
lf发布了新的文献求助10
11秒前
KDVBHGJDFHGAV应助优秀不愁采纳,获得10
11秒前
从容的毛豆完成签到,获得积分10
12秒前
12秒前
zk完成签到 ,获得积分10
12秒前
13秒前
苏苏828完成签到,获得积分10
14秒前
14秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Instituting Science: The Cultural Production of Scientific Disciplines 666
Signals, Systems, and Signal Processing 610
The Organization of knowledge in modern America, 1860-1920 / 600
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6360199
求助须知:如何正确求助?哪些是违规求助? 8174338
关于积分的说明 17217139
捐赠科研通 5415065
什么是DOI,文献DOI怎么找? 2865763
邀请新用户注册赠送积分活动 1843057
关于科研通互助平台的介绍 1691274